Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evoke Pharma

2.72
+0.03001.12%
Post-market: 2.720.00000.00%13:25 EDT
Volume:25.03K
Turnover:69.12K
Market Cap:4.06M
PE:-0.97
High:2.84
Open:2.78
Low:2.70
Close:2.69
Loading ...
May 22, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 24, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 29, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 28, 2024

Major Issues Report

Form 8-K - Current report
Oct 22, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Sep 20, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 04, 2024

Correspondence

Form CORRESP - Correspondence
Aug 20, 2024

Correspondence

Form CORRESP - Correspondence